

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | locomotory exploration behavior (GO:0035641) | 6.15101320 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.72450800 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.70952106 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.68589990 |
| 5 | vocalization behavior (GO:0071625) | 5.18115857 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.14299910 |
| 7 | glutamate secretion (GO:0014047) | 5.12598927 |
| 8 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.04318950 |
| 9 | central nervous system myelination (GO:0022010) | 4.92986898 |
| 10 | axon ensheathment in central nervous system (GO:0032291) | 4.92986898 |
| 11 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.92018482 |
| 12 | cellular potassium ion homeostasis (GO:0030007) | 4.85095405 |
| 13 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.79546846 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.75135080 |
| 15 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.64091753 |
| 16 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.63727241 |
| 17 | sodium ion export (GO:0071436) | 4.59490152 |
| 18 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.51763153 |
| 19 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.50025230 |
| 20 | regulation of synapse structural plasticity (GO:0051823) | 4.49494153 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.41181430 |
| 22 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.41019383 |
| 23 | gamma-aminobutyric acid transport (GO:0015812) | 4.40385019 |
| 24 | exploration behavior (GO:0035640) | 4.37677363 |
| 25 | neuronal action potential propagation (GO:0019227) | 4.34080421 |
| 26 | protein localization to synapse (GO:0035418) | 4.32199263 |
| 27 | neurotransmitter secretion (GO:0007269) | 4.25279851 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 4.22955436 |
| 29 | synaptic transmission, glutamatergic (GO:0035249) | 4.19758889 |
| 30 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 4.17721296 |
| 31 | neurotransmitter uptake (GO:0001504) | 4.12706789 |
| 32 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.07272237 |
| 33 | neuron cell-cell adhesion (GO:0007158) | 4.04313040 |
| 34 | long-term memory (GO:0007616) | 4.03852362 |
| 35 | regulation of synaptic vesicle transport (GO:1902803) | 3.97398710 |
| 36 | presynaptic membrane organization (GO:0097090) | 3.95085453 |
| 37 | response to auditory stimulus (GO:0010996) | 3.93584816 |
| 38 | layer formation in cerebral cortex (GO:0021819) | 3.90769785 |
| 39 | dendritic spine morphogenesis (GO:0060997) | 3.84723131 |
| 40 | neuron-neuron synaptic transmission (GO:0007270) | 3.84435462 |
| 41 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.82997017 |
| 42 | auditory behavior (GO:0031223) | 3.80762772 |
| 43 | cell communication by electrical coupling (GO:0010644) | 3.74453453 |
| 44 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.74166806 |
| 45 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.73974353 |
| 46 | positive regulation of membrane potential (GO:0045838) | 3.73488010 |
| 47 | proline transport (GO:0015824) | 3.72314977 |
| 48 | * L-amino acid import (GO:0043092) | 3.71050250 |
| 49 | regulation of synaptic plasticity (GO:0048167) | 3.65721443 |
| 50 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.64608872 |
| 51 | long-term synaptic potentiation (GO:0060291) | 3.57043745 |
| 52 | potassium ion import (GO:0010107) | 3.56099212 |
| 53 | prepulse inhibition (GO:0060134) | 3.55472946 |
| 54 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.53039368 |
| 55 | regulation of postsynaptic membrane potential (GO:0060078) | 3.52924977 |
| 56 | neurotransmitter transport (GO:0006836) | 3.52484854 |
| 57 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.50201694 |
| 58 | regulation of synapse maturation (GO:0090128) | 3.49723698 |
| 59 | neuromuscular process controlling balance (GO:0050885) | 3.47129451 |
| 60 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.46485443 |
| 61 | cellular sodium ion homeostasis (GO:0006883) | 3.45539807 |
| 62 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.37866880 |
| 63 | alanine transport (GO:0032328) | 3.37389037 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 3.35806397 |
| 65 | transmission of nerve impulse (GO:0019226) | 3.33205579 |
| 66 | response to histamine (GO:0034776) | 3.28944870 |
| 67 | potassium ion homeostasis (GO:0055075) | 3.25902240 |
| 68 | dendrite morphogenesis (GO:0048813) | 3.25394389 |
| 69 | activation of protein kinase A activity (GO:0034199) | 3.23953311 |
| 70 | postsynaptic membrane organization (GO:0001941) | 3.22089300 |
| 71 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.21812101 |
| 72 | cell communication involved in cardiac conduction (GO:0086065) | 3.19203553 |
| 73 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.18427241 |
| 74 | synaptic vesicle endocytosis (GO:0048488) | 3.17728285 |
| 75 | regulation of neurotransmitter secretion (GO:0046928) | 3.17566064 |
| 76 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.17263979 |
| 77 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.16026087 |
| 78 | membrane hyperpolarization (GO:0060081) | 3.13146573 |
| 79 | detection of calcium ion (GO:0005513) | 3.12584678 |
| 80 | neuromuscular process (GO:0050905) | 3.11343236 |
| 81 | regulation of ARF protein signal transduction (GO:0032012) | 3.10922391 |
| 82 | startle response (GO:0001964) | 3.10748336 |
| 83 | glycine transport (GO:0015816) | 3.10569446 |
| 84 | * synaptic transmission (GO:0007268) | 3.10426768 |
| 85 | positive regulation of synapse maturation (GO:0090129) | 3.09632241 |
| 86 | positive regulation of synaptic transmission (GO:0050806) | 3.09046197 |
| 87 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.09040492 |
| 88 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.08499806 |
| 89 | serotonin metabolic process (GO:0042428) | 3.06885288 |
| 90 | regulation of vesicle fusion (GO:0031338) | 3.06466716 |
| 91 | * amino acid import (GO:0043090) | 3.06029430 |
| 92 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.05216645 |
| 93 | regulation of neurotransmitter transport (GO:0051588) | 3.04728537 |
| 94 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.04504700 |
| 95 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.04453794 |
| 96 | mechanosensory behavior (GO:0007638) | 3.03394063 |
| 97 | neuronal ion channel clustering (GO:0045161) | 3.03041633 |
| 98 | neuromuscular synaptic transmission (GO:0007274) | 3.02857403 |
| 99 | cerebellar granule cell differentiation (GO:0021707) | 3.02827865 |
| 100 | positive regulation of neurotransmitter transport (GO:0051590) | 3.02501233 |
| 101 | presynaptic membrane assembly (GO:0097105) | 2.99132825 |
| 102 | adult walking behavior (GO:0007628) | 2.99019254 |
| 103 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.98595425 |
| 104 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.97713112 |
| 105 | behavioral defense response (GO:0002209) | 2.97589393 |
| 106 | behavioral fear response (GO:0001662) | 2.97589393 |
| 107 | cell differentiation in hindbrain (GO:0021533) | 2.97135755 |
| 108 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.95733513 |
| 109 | membrane depolarization (GO:0051899) | 2.95615219 |
| 110 | regulation of synaptic transmission (GO:0050804) | 2.95271811 |
| 111 | regulation of dendritic spine development (GO:0060998) | 2.94493258 |
| 112 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94418174 |
| 113 | learning (GO:0007612) | 2.93902277 |
| 114 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.91781555 |
| 115 | membrane depolarization during action potential (GO:0086010) | 2.91577166 |
| 116 | neuromuscular process controlling posture (GO:0050884) | 2.91041191 |
| 117 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.90124087 |
| 118 | positive regulation of dendritic spine development (GO:0060999) | 2.89249896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.46247597 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27133695 |
| 3 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.06099714 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.03850513 |
| 5 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.93165823 |
| 6 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.65838500 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.65838500 |
| 8 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.65448842 |
| 9 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.64863657 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.58439442 |
| 11 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.56047752 |
| 12 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54540097 |
| 13 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.54085947 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.52870608 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.47155948 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.42606511 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.35294323 |
| 18 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.30040499 |
| 19 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.19407206 |
| 20 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.19052511 |
| 21 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18166809 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15029616 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.13353253 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.10505206 |
| 25 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.01685548 |
| 26 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.91135363 |
| 27 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.75218227 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73329825 |
| 29 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73213370 |
| 30 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.72570228 |
| 31 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.72010882 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.69594588 |
| 33 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60709430 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.56595215 |
| 35 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.53117402 |
| 36 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46786042 |
| 37 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.46158431 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42392670 |
| 39 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.38489781 |
| 40 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.38210920 |
| 41 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.36619251 |
| 42 | P300_19829295_ChIP-Seq_ESCs_Human | 1.30584154 |
| 43 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29978068 |
| 44 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.29641536 |
| 45 | AR_25329375_ChIP-Seq_VCAP_Human | 1.27939550 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27393747 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26778631 |
| 48 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.26025783 |
| 49 | * AR_19668381_ChIP-Seq_PC3_Human | 1.26016047 |
| 50 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.24554421 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24420251 |
| 52 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24009584 |
| 53 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.22707449 |
| 54 | RXR_22108803_ChIP-Seq_LS180_Human | 1.21637515 |
| 55 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20377523 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.20079358 |
| 57 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.19208478 |
| 58 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.17041078 |
| 59 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.16757604 |
| 60 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.16304716 |
| 61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14584719 |
| 62 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13695792 |
| 63 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13301729 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.13090947 |
| 65 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.12424496 |
| 66 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11498515 |
| 67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10973360 |
| 68 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10134263 |
| 69 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09869636 |
| 70 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09665143 |
| 71 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09119911 |
| 72 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05620551 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05589104 |
| 74 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.05448833 |
| 75 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.04651503 |
| 76 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.03490082 |
| 77 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03468060 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.02772288 |
| 79 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02046737 |
| 80 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.00961726 |
| 81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00768732 |
| 82 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.99895628 |
| 83 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99059173 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99051384 |
| 85 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.98890737 |
| 86 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.98573059 |
| 87 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.98510676 |
| 88 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.98245122 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97830384 |
| 90 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96161586 |
| 91 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.96035539 |
| 92 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95497158 |
| 93 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94372073 |
| 94 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.93747561 |
| 95 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.92988483 |
| 96 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92901100 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92057589 |
| 98 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91919658 |
| 99 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90677857 |
| 100 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.90677857 |
| 101 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.90431090 |
| 102 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.90387679 |
| 103 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90237408 |
| 104 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90078483 |
| 105 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89295187 |
| 106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89118699 |
| 107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.88970820 |
| 108 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.88821089 |
| 109 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.88004466 |
| 110 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87920893 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.87698350 |
| 112 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.86817390 |
| 113 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85828358 |
| 114 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.85089424 |
| 115 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.83907993 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.83647765 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.88939531 |
| 2 | MP0003880_abnormal_central_pattern | 4.21035042 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.19171880 |
| 4 | MP0004270_analgesia | 3.70285377 |
| 5 | * MP0009745_abnormal_behavioral_response | 3.39831784 |
| 6 | MP0002063_abnormal_learning/memory/cond | 3.38043697 |
| 7 | MP0002822_catalepsy | 3.27499865 |
| 8 | * MP0002064_seizures | 3.17425324 |
| 9 | MP0009046_muscle_twitch | 3.10503517 |
| 10 | MP0001486_abnormal_startle_reflex | 3.06427726 |
| 11 | MP0002572_abnormal_emotion/affect_behav | 2.87641229 |
| 12 | MP0005423_abnormal_somatic_nervous | 2.84503344 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.72038927 |
| 14 | MP0002272_abnormal_nervous_system | 2.56563318 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.45232706 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.32840416 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.32813836 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.31105517 |
| 19 | MP0004858_abnormal_nervous_system | 2.27969276 |
| 20 | MP0004885_abnormal_endolymph | 2.21251281 |
| 21 | MP0008569_lethality_at_weaning | 2.18614824 |
| 22 | MP0001440_abnormal_grooming_behavior | 2.06984708 |
| 23 | MP0002736_abnormal_nociception_after | 2.00411120 |
| 24 | MP0003690_abnormal_glial_cell | 1.92234318 |
| 25 | MP0002067_abnormal_sensory_capabilities | 1.89722067 |
| 26 | MP0003329_amyloid_beta_deposits | 1.87233490 |
| 27 | MP0002733_abnormal_thermal_nociception | 1.77614800 |
| 28 | MP0001970_abnormal_pain_threshold | 1.75834873 |
| 29 | MP0002557_abnormal_social/conspecific_i | 1.75504295 |
| 30 | MP0002909_abnormal_adrenal_gland | 1.72513914 |
| 31 | MP0001984_abnormal_olfaction | 1.63391366 |
| 32 | MP0004924_abnormal_behavior | 1.61255384 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.61255384 |
| 34 | MP0000778_abnormal_nervous_system | 1.59745621 |
| 35 | MP0002735_abnormal_chemical_nociception | 1.58179134 |
| 36 | * MP0003633_abnormal_nervous_system | 1.58050654 |
| 37 | MP0001502_abnormal_circadian_rhythm | 1.57925916 |
| 38 | MP0004811_abnormal_neuron_physiology | 1.56988395 |
| 39 | MP0003075_altered_response_to | 1.50397180 |
| 40 | MP0003879_abnormal_hair_cell | 1.46224377 |
| 41 | MP0002066_abnormal_motor_capabilities/c | 1.36806426 |
| 42 | * MP0002882_abnormal_neuron_morphology | 1.36674122 |
| 43 | MP0002184_abnormal_innervation | 1.34411285 |
| 44 | * MP0000955_abnormal_spinal_cord | 1.32516105 |
| 45 | * MP0003631_nervous_system_phenotype | 1.28040334 |
| 46 | MP0003122_maternal_imprinting | 1.27185655 |
| 47 | MP0005551_abnormal_eye_electrophysiolog | 1.26599778 |
| 48 | MP0005645_abnormal_hypothalamus_physiol | 1.22306962 |
| 49 | MP0004142_abnormal_muscle_tone | 1.18856868 |
| 50 | MP0002090_abnormal_vision | 1.16564843 |
| 51 | MP0001529_abnormal_vocalization | 1.15308637 |
| 52 | MP0001485_abnormal_pinna_reflex | 1.15219855 |
| 53 | MP0001905_abnormal_dopamine_level | 1.14469463 |
| 54 | MP0003634_abnormal_glial_cell | 1.12359923 |
| 55 | MP0003123_paternal_imprinting | 1.08570148 |
| 56 | MP0005167_abnormal_blood-brain_barrier | 1.08480370 |
| 57 | * MP0002152_abnormal_brain_morphology | 1.08473422 |
| 58 | MP0008872_abnormal_physiological_respon | 1.07837106 |
| 59 | MP0004147_increased_porphyrin_level | 1.07195636 |
| 60 | MP0001177_atelectasis | 1.07019767 |
| 61 | MP0008874_decreased_physiological_sensi | 1.02683177 |
| 62 | MP0002229_neurodegeneration | 0.99213829 |
| 63 | MP0000920_abnormal_myelination | 0.99040106 |
| 64 | MP0008961_abnormal_basal_metabolism | 0.92792799 |
| 65 | MP0003787_abnormal_imprinting | 0.92488337 |
| 66 | MP0002638_abnormal_pupillary_reflex | 0.91956273 |
| 67 | MP0003632_abnormal_nervous_system | 0.91878925 |
| 68 | MP0002069_abnormal_eating/drinking_beha | 0.89461301 |
| 69 | MP0001963_abnormal_hearing_physiology | 0.88837235 |
| 70 | MP0000604_amyloidosis | 0.86930116 |
| 71 | MP0004215_abnormal_myocardial_fiber | 0.86253985 |
| 72 | MP0004043_abnormal_pH_regulation | 0.85905721 |
| 73 | MP0005535_abnormal_body_temperature | 0.84840432 |
| 74 | MP0003137_abnormal_impulse_conducting | 0.82239377 |
| 75 | MP0000751_myopathy | 0.80911357 |
| 76 | MP0004085_abnormal_heartbeat | 0.80671374 |
| 77 | MP0004742_abnormal_vestibular_system | 0.79644260 |
| 78 | MP0001986_abnormal_taste_sensitivity | 0.77010475 |
| 79 | MP0001188_hyperpigmentation | 0.76846744 |
| 80 | MP0005409_darkened_coat_color | 0.76259513 |
| 81 | MP0001346_abnormal_lacrimal_gland | 0.76153538 |
| 82 | MP0000631_abnormal_neuroendocrine_gland | 0.75693174 |
| 83 | MP0006276_abnormal_autonomic_nervous | 0.75377062 |
| 84 | MP0001348_abnormal_lacrimal_gland | 0.74412805 |
| 85 | MP0005394_taste/olfaction_phenotype | 0.72485061 |
| 86 | MP0005499_abnormal_olfactory_system | 0.72485061 |
| 87 | MP0010386_abnormal_urinary_bladder | 0.71065971 |
| 88 | MP0000569_abnormal_digit_pigmentation | 0.70785335 |
| 89 | MP0000013_abnormal_adipose_tissue | 0.70485953 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.69845096 |
| 91 | MP0002752_abnormal_somatic_nervous | 0.67507277 |
| 92 | MP0001299_abnormal_eye_distance/ | 0.66957071 |
| 93 | MP0003283_abnormal_digestive_organ | 0.66935521 |
| 94 | MP0004130_abnormal_muscle_cell | 0.64910913 |
| 95 | MP0005166_decreased_susceptibility_to | 0.62245966 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.61034873 |
| 97 | MP0005253_abnormal_eye_physiology | 0.60037351 |
| 98 | MP0000579_abnormal_nail_morphology | 0.57201581 |
| 99 | MP0004233_abnormal_muscle_weight | 0.56813289 |
| 100 | MP0001664_abnormal_digestion | 0.56061668 |
| 101 | MP0003646_muscle_fatigue | 0.55447080 |
| 102 | MP0004145_abnormal_muscle_electrophysio | 0.54611759 |
| 103 | MP0002089_abnormal_postnatal_growth/wei | 0.54154304 |
| 104 | * MP0010768_mortality/aging | 0.53822808 |
| 105 | * MP0002082_postnatal_lethality | 0.53233270 |
| 106 | * MP0010770_preweaning_lethality | 0.53233270 |
| 107 | MP0005623_abnormal_meninges_morphology | 0.51334263 |
| 108 | MP0000026_abnormal_inner_ear | 0.50768124 |
| 109 | * MP0010769_abnormal_survival | 0.49881382 |
| 110 | MP0001943_abnormal_respiration | 0.49810866 |
| 111 | MP0005595_abnormal_vascular_smooth | 0.49594711 |
| 112 | MP0003956_abnormal_body_size | 0.49227339 |
| 113 | MP0000566_synostosis | 0.48821090 |
| 114 | MP0003861_abnormal_nervous_system | 0.48575195 |
| 115 | MP0004484_altered_response_of | 0.47948016 |
| 116 | MP0003121_genomic_imprinting | 0.47654330 |
| 117 | MP0008877_abnormal_DNA_methylation | 0.44312822 |
| 118 | MP0000639_abnormal_adrenal_gland | 0.44049316 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.03028433 |
| 2 | Myokymia (HP:0002411) | 7.19121578 |
| 3 | Focal seizures (HP:0007359) | 5.62440793 |
| 4 | Epileptic encephalopathy (HP:0200134) | 5.03932334 |
| 5 | Action tremor (HP:0002345) | 4.41383583 |
| 6 | Visual hallucinations (HP:0002367) | 4.36136821 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.22082757 |
| 8 | Febrile seizures (HP:0002373) | 4.11800969 |
| 9 | Generalized tonic-clonic seizures (HP:0002069) | 4.04903687 |
| 10 | Megalencephaly (HP:0001355) | 3.95653805 |
| 11 | Absence seizures (HP:0002121) | 3.90667165 |
| 12 | Dysdiadochokinesis (HP:0002075) | 3.89303200 |
| 13 | Atonic seizures (HP:0010819) | 3.70866165 |
| 14 | Dialeptic seizures (HP:0011146) | 3.65373934 |
| 15 | Aplasia involving bones of the extremities (HP:0009825) | 3.59583446 |
| 16 | Aplasia involving bones of the upper limbs (HP:0009823) | 3.59583446 |
| 17 | Aplasia of the phalanges of the hand (HP:0009802) | 3.59583446 |
| 18 | Postural instability (HP:0002172) | 3.54887892 |
| 19 | Broad-based gait (HP:0002136) | 3.41916665 |
| 20 | Hyperventilation (HP:0002883) | 3.41567564 |
| 21 | Hemiplegia (HP:0002301) | 3.37142392 |
| 22 | Gaze-evoked nystagmus (HP:0000640) | 3.37080314 |
| 23 | Hemiparesis (HP:0001269) | 3.31168039 |
| 24 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.31041240 |
| 25 | Poor eye contact (HP:0000817) | 3.29742411 |
| 26 | Depression (HP:0000716) | 3.28641542 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 3.24957096 |
| 28 | Abnormal eating behavior (HP:0100738) | 3.20021673 |
| 29 | Dysmetria (HP:0001310) | 3.17206637 |
| 30 | Ankle clonus (HP:0011448) | 3.11616709 |
| 31 | Abnormality of binocular vision (HP:0011514) | 3.11467417 |
| 32 | Diplopia (HP:0000651) | 3.11467417 |
| 33 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.08744219 |
| 34 | Truncal ataxia (HP:0002078) | 3.06448199 |
| 35 | Impaired social interactions (HP:0000735) | 3.05014928 |
| 36 | Abnormal social behavior (HP:0012433) | 3.05014928 |
| 37 | Anxiety (HP:0000739) | 3.04708584 |
| 38 | Papilledema (HP:0001085) | 2.94957815 |
| 39 | Intention tremor (HP:0002080) | 2.93169798 |
| 40 | Abnormality of the corticospinal tract (HP:0002492) | 2.93115183 |
| 41 | Limb dystonia (HP:0002451) | 2.90060194 |
| 42 | Status epilepticus (HP:0002133) | 2.89476739 |
| 43 | Genetic anticipation (HP:0003743) | 2.85597810 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.78588373 |
| 45 | Cerebral hypomyelination (HP:0006808) | 2.77035885 |
| 46 | Impaired smooth pursuit (HP:0007772) | 2.69125452 |
| 47 | Akinesia (HP:0002304) | 2.68908068 |
| 48 | Torticollis (HP:0000473) | 2.63312192 |
| 49 | Bradykinesia (HP:0002067) | 2.62861810 |
| 50 | Scanning speech (HP:0002168) | 2.61119572 |
| 51 | Stereotypic behavior (HP:0000733) | 2.59962900 |
| 52 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.57974262 |
| 53 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.57974262 |
| 54 | Dysmetric saccades (HP:0000641) | 2.54384855 |
| 55 | Delusions (HP:0000746) | 2.50431376 |
| 56 | Impaired vibratory sensation (HP:0002495) | 2.49214773 |
| 57 | Focal dystonia (HP:0004373) | 2.45580227 |
| 58 | Clumsiness (HP:0002312) | 2.45390056 |
| 59 | Annular pancreas (HP:0001734) | 2.41475056 |
| 60 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.40890439 |
| 61 | Urinary urgency (HP:0000012) | 2.40601906 |
| 62 | Cerebral inclusion bodies (HP:0100314) | 2.38742160 |
| 63 | Drooling (HP:0002307) | 2.38443363 |
| 64 | Excessive salivation (HP:0003781) | 2.38443363 |
| 65 | Sleep apnea (HP:0010535) | 2.31756612 |
| 66 | Spastic gait (HP:0002064) | 2.29526741 |
| 67 | Amblyopia (HP:0000646) | 2.27942385 |
| 68 | Epileptiform EEG discharges (HP:0011182) | 2.26787843 |
| 69 | Spastic tetraparesis (HP:0001285) | 2.21141967 |
| 70 | Apathy (HP:0000741) | 2.20578530 |
| 71 | Mutism (HP:0002300) | 2.20527422 |
| 72 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18497422 |
| 73 | Obstructive sleep apnea (HP:0002870) | 2.17869905 |
| 74 | Abnormality of the lower motor neuron (HP:0002366) | 2.13703233 |
| 75 | Generalized myoclonic seizures (HP:0002123) | 2.13039909 |
| 76 | Craniofacial dystonia (HP:0012179) | 2.12325442 |
| 77 | Split foot (HP:0001839) | 2.08094537 |
| 78 | Ventricular fibrillation (HP:0001663) | 2.07510830 |
| 79 | Hypsarrhythmia (HP:0002521) | 2.07383271 |
| 80 | Lower limb muscle weakness (HP:0007340) | 2.05096071 |
| 81 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.01017462 |
| 82 | Choreoathetosis (HP:0001266) | 2.00227064 |
| 83 | Abnormality of the periventricular white matter (HP:0002518) | 1.97270693 |
| 84 | Abnormality of saccadic eye movements (HP:0000570) | 1.97263205 |
| 85 | Polyphagia (HP:0002591) | 1.97231900 |
| 86 | Tetraplegia (HP:0002445) | 1.96241678 |
| 87 | Rigidity (HP:0002063) | 1.95402926 |
| 88 | Rapidly progressive (HP:0003678) | 1.95058828 |
| 89 | Incomplete penetrance (HP:0003829) | 1.94065954 |
| 90 | CNS hypomyelination (HP:0003429) | 1.93006666 |
| 91 | Diminished motivation (HP:0000745) | 1.92540556 |
| 92 | Severe global developmental delay (HP:0011344) | 1.90220211 |
| 93 | Pointed chin (HP:0000307) | 1.89489099 |
| 94 | Gait ataxia (HP:0002066) | 1.89020063 |
| 95 | Increased circulating renin level (HP:0000848) | 1.88804770 |
| 96 | Absent speech (HP:0001344) | 1.88723735 |
| 97 | Fetal akinesia sequence (HP:0001989) | 1.88464225 |
| 98 | Ankyloglossia (HP:0010296) | 1.88013861 |
| 99 | Prolonged QT interval (HP:0001657) | 1.86145563 |
| 100 | Abnormal EKG (HP:0003115) | 1.85774213 |
| 101 | Blue irides (HP:0000635) | 1.85739921 |
| 102 | Memory impairment (HP:0002354) | 1.80513431 |
| 103 | Progressive inability to walk (HP:0002505) | 1.80340761 |
| 104 | Resting tremor (HP:0002322) | 1.79478774 |
| 105 | Pheochromocytoma (HP:0002666) | 1.77103267 |
| 106 | Clonus (HP:0002169) | 1.74750376 |
| 107 | Bronchomalacia (HP:0002780) | 1.73389902 |
| 108 | Spinal canal stenosis (HP:0003416) | 1.71854850 |
| 109 | Thickened helices (HP:0000391) | 1.71539457 |
| 110 | Spastic tetraplegia (HP:0002510) | 1.70438668 |
| 111 | Psychosis (HP:0000709) | 1.68916756 |
| 112 | Neuronal loss in central nervous system (HP:0002529) | 1.68317491 |
| 113 | Bundle branch block (HP:0011710) | 1.65211517 |
| 114 | Lower limb asymmetry (HP:0100559) | 1.65128523 |
| 115 | Peripheral hypomyelination (HP:0007182) | 1.65053443 |
| 116 | Limb ataxia (HP:0002070) | 1.64230365 |
| 117 | Abnormality of salivation (HP:0100755) | 1.63903821 |
| 118 | Insomnia (HP:0100785) | 1.63865220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.41851930 |
| 2 | NTRK3 | 4.13901686 |
| 3 | MAP3K9 | 3.35900335 |
| 4 | PRKD3 | 2.94405337 |
| 5 | NTRK2 | 2.83271969 |
| 6 | MAP3K4 | 2.59570620 |
| 7 | DAPK2 | 2.56021120 |
| 8 | TNIK | 2.52739240 |
| 9 | MINK1 | 2.36095319 |
| 10 | MAP2K7 | 2.16073598 |
| 11 | PAK6 | 2.08005803 |
| 12 | MARK1 | 2.03345216 |
| 13 | CAMKK1 | 2.02707702 |
| 14 | NTRK1 | 1.96417718 |
| 15 | KSR2 | 1.93962721 |
| 16 | RIPK4 | 1.87563105 |
| 17 | CASK | 1.83951080 |
| 18 | MAP2K4 | 1.61127947 |
| 19 | PRPF4B | 1.56650979 |
| 20 | CDK5 | 1.55814786 |
| 21 | SGK2 | 1.47353012 |
| 22 | STK38 | 1.45229935 |
| 23 | MAP3K13 | 1.39748000 |
| 24 | DAPK1 | 1.39295357 |
| 25 | SGK223 | 1.38415349 |
| 26 | SGK494 | 1.38415349 |
| 27 | KSR1 | 1.36941510 |
| 28 | SGK3 | 1.30236152 |
| 29 | MUSK | 1.30141511 |
| 30 | LMTK2 | 1.27423139 |
| 31 | PHKG1 | 1.26375192 |
| 32 | PHKG2 | 1.26375192 |
| 33 | FES | 1.26342082 |
| 34 | TYRO3 | 1.25099779 |
| 35 | MAPK13 | 1.24182177 |
| 36 | CDK19 | 1.19378504 |
| 37 | PRKCG | 1.16094859 |
| 38 | PINK1 | 1.13295104 |
| 39 | SIK2 | 1.10594674 |
| 40 | MAP3K12 | 1.04609210 |
| 41 | PLK2 | 1.04287517 |
| 42 | CAMK1 | 1.01613742 |
| 43 | MAP3K2 | 0.99016697 |
| 44 | TAOK1 | 0.97537051 |
| 45 | CAMKK2 | 0.96560735 |
| 46 | PRKCH | 0.95790506 |
| 47 | ARAF | 0.95259956 |
| 48 | TRIB3 | 0.93896970 |
| 49 | GRK5 | 0.93099205 |
| 50 | STK11 | 0.91466375 |
| 51 | CAMK2A | 0.90064414 |
| 52 | SGK1 | 0.82492607 |
| 53 | CDK15 | 0.78666982 |
| 54 | CDK18 | 0.78448305 |
| 55 | PDK1 | 0.77009385 |
| 56 | RET | 0.76526683 |
| 57 | UHMK1 | 0.74846762 |
| 58 | PDPK1 | 0.74759609 |
| 59 | DMPK | 0.73949576 |
| 60 | PKN1 | 0.72319036 |
| 61 | CDK14 | 0.72200426 |
| 62 | MAP3K7 | 0.71357510 |
| 63 | PTK2B | 0.69439416 |
| 64 | RAF1 | 0.69052744 |
| 65 | PAK3 | 0.67637347 |
| 66 | CAMK1G | 0.67592041 |
| 67 | CDK11A | 0.66959429 |
| 68 | CAMK2B | 0.66601208 |
| 69 | NEK6 | 0.65402548 |
| 70 | TNK2 | 0.65393348 |
| 71 | PNCK | 0.63941117 |
| 72 | OXSR1 | 0.63790369 |
| 73 | BMPR2 | 0.63137453 |
| 74 | FGFR2 | 0.61619342 |
| 75 | RPS6KA3 | 0.60072389 |
| 76 | ROCK2 | 0.58826859 |
| 77 | DYRK1A | 0.58390371 |
| 78 | ALK | 0.57469247 |
| 79 | RIPK1 | 0.56686605 |
| 80 | MARK2 | 0.55821154 |
| 81 | CAMK4 | 0.54826597 |
| 82 | LATS2 | 0.53542333 |
| 83 | CCNB1 | 0.52697469 |
| 84 | CDC42BPA | 0.52502811 |
| 85 | BRSK1 | 0.50342742 |
| 86 | MAP3K1 | 0.50310989 |
| 87 | BRAF | 0.49085338 |
| 88 | PRKCE | 0.46497669 |
| 89 | PRKCZ | 0.45921917 |
| 90 | MAPK10 | 0.45914755 |
| 91 | CAMK2G | 0.45510719 |
| 92 | FGR | 0.45472767 |
| 93 | MAPK12 | 0.44593791 |
| 94 | FYN | 0.43530567 |
| 95 | CSNK1G2 | 0.39871767 |
| 96 | ROCK1 | 0.37468127 |
| 97 | PRKG1 | 0.37168875 |
| 98 | MAP3K11 | 0.37050752 |
| 99 | PRKCA | 0.36717506 |
| 100 | PRKD2 | 0.36598487 |
| 101 | CAMK2D | 0.35840063 |
| 102 | PRKCB | 0.33089941 |
| 103 | CSNK1D | 0.32484850 |
| 104 | MAP2K1 | 0.31710123 |
| 105 | BMX | 0.31649185 |
| 106 | ERBB2 | 0.30483606 |
| 107 | PIK3CA | 0.30432228 |
| 108 | MAPK7 | 0.30344025 |
| 109 | CSNK1A1 | 0.30295767 |
| 110 | WNK1 | 0.30285870 |
| 111 | PRKCQ | 0.29938205 |
| 112 | LIMK1 | 0.29817618 |
| 113 | MAPKAPK5 | 0.28622553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.95157383 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.31935625 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.66503249 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.64606107 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.63894007 |
| 6 | Circadian entrainment_Homo sapiens_hsa04713 | 2.54483125 |
| 7 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.50813685 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.39987865 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.37548331 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.36852312 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 2.23003026 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.19892393 |
| 13 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.15855152 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.05261033 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 2.02862073 |
| 16 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.02651633 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82060746 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.77474526 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.74696417 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.57949201 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56029399 |
| 22 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.53308451 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.52141748 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.46023004 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45848052 |
| 26 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.40881012 |
| 27 | Long-term depression_Homo sapiens_hsa04730 | 1.36888338 |
| 28 | Taste transduction_Homo sapiens_hsa04742 | 1.35089884 |
| 29 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.32746147 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.31966388 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.29680631 |
| 32 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.28933468 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.16468726 |
| 34 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.14742917 |
| 35 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.11039098 |
| 36 | Glioma_Homo sapiens_hsa05214 | 1.06519347 |
| 37 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.03326878 |
| 38 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.02041596 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 0.98549961 |
| 40 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.97432894 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97398929 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96923579 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.96179060 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.96044923 |
| 45 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.95726655 |
| 46 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.95312941 |
| 47 | Melanogenesis_Homo sapiens_hsa04916 | 0.94546728 |
| 48 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89827220 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.87791126 |
| 50 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.86651538 |
| 51 | Circadian rhythm_Homo sapiens_hsa04710 | 0.85117681 |
| 52 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84928360 |
| 53 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.83708398 |
| 54 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82165605 |
| 55 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81721277 |
| 56 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.78143744 |
| 57 | Axon guidance_Homo sapiens_hsa04360 | 0.74421275 |
| 58 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70411422 |
| 59 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.69946223 |
| 60 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.69594297 |
| 61 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.68925231 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68885337 |
| 63 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67620797 |
| 64 | Phototransduction_Homo sapiens_hsa04744 | 0.64774001 |
| 65 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63607046 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.62885607 |
| 67 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.59185013 |
| 68 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.57586539 |
| 69 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.55640122 |
| 70 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53874019 |
| 71 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.52690648 |
| 72 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50526639 |
| 73 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50403262 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48936774 |
| 75 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45770490 |
| 76 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45366664 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.44086289 |
| 78 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42682632 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41858993 |
| 80 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41745208 |
| 81 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40670088 |
| 82 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40246759 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39706366 |
| 84 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.39442798 |
| 85 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.38579741 |
| 86 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36547803 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.36040538 |
| 88 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.35873989 |
| 89 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.35230148 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35080831 |
| 91 | Alcoholism_Homo sapiens_hsa05034 | 0.34041000 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.34033743 |
| 93 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33046560 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31476981 |
| 95 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30562351 |
| 96 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30462592 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.29285626 |
| 98 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28997303 |
| 99 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.28782100 |
| 100 | Prion diseases_Homo sapiens_hsa05020 | 0.28464486 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.28203049 |
| 102 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27167505 |
| 103 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.26090892 |
| 104 | Tight junction_Homo sapiens_hsa04530 | 0.26005047 |
| 105 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24286697 |
| 106 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.23384822 |
| 107 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.22444545 |
| 108 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.21031001 |
| 109 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.20629306 |
| 110 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.18857186 |
| 111 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.18387816 |

